Skip to main content
. 2023 Jan 4;12(2):418. doi: 10.3390/jcm12020418

Table 2.

Pregnancy outcome of the patients included in the main groups.

Pregnancy Outcome Group 1 (PE, n = 116) Group 2 (Without PE, n = 116) p Value
Placenta praevia (n/%) Yes = 5 (4.31%) Yes = 7 (6.03%) 0.55
Preterm birth (n/%) Yes = 51 (43.97%) ** Yes = 5 (4.31%) <0.001
Intrauterine growth restriction (n/%) Yes = 48 (41.38%) ** Yes = 5 (4.31%) <0.001
Oligoamnios (n/%) Yes = 8 (6.90%) ** Yes= 1 (0.86%) 0.01
Polyhydramnios (n/%) Yes = 0 (0%) Yes= 5 (4.31%) ** 0.02
PE related complications (n/%) Eclampsia = 2 (1.72%)
bruptio placentae = 3 (2.58%)
HELLP syndrome = 3 (2.58%)
- -
Newborn’s gender (n/%) Male = 60 (51.72%)
Female = 56 (48.28%)
Male = 59 (26.72%)
Female = 57 (49.14%)
0.89
Gestational age at birth, weeks (mean ± SD) 35.87± 3.41 ** 38.37 ± 1.40 <0.001
Mode of delivery (n/%) Cesarean = 112 (96.55%) **
Vaginal = 4 (3.45%) **
Cesarean = 72 (62.07%)
Vaginal = 44 (37.93%)
<0.001
Presentation (n/%) Cephalic = 105 (90.52%)
Breech = 10 (8.62%)
Transverse = 1(0.86%)
Cephalic = 108 (93.10%)
Breech = 8 (6.90%)
Transverse = 0 (0%)
0.53
Apgar score at 1 min (mean ± SD) 7.25 ± 1.86 ** 8.37 ± 0.88 <0.001
Apgar score at 5 min (mean ± SD) 7.98 ± 1.36 ** 8.84 ± 0.71 <0.001
Birthweight, g (mean ± SD) 2519.91 ± 946.60 ** 3240 ± 457.60 <0.001
Newborn’s length, cm (mean ± SD) 46.39 ± 6.00 ** 50.79 ± 2.27 <0.001

Table 2 legend: PE—preeclampsia; SD—standard deviation; g—grams. Tests used: chi-squared for categorical variables, and t-tests for continuous variables; ** the data from which statistical significance originates.